IGC Pharma, Inc. (FRA:IGS1)
Germany · Delayed Price · Currency is EUR 0.2740
0.00 (0.00%)
At close: Nov 28, 2025
IGC Pharma Cash Flow Statement
Financials in millions USD. Fiscal year is April - March.
Millions USD. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2016 - 2020 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2016 - 2020 |
Net Income | -6.45 | -7.12 | -13 | -11.51 | -15.02 | -8.81 | Upgrade |
Depreciation & Amortization | 0.57 | 0.62 | 0.64 | 0.66 | 0.65 | 0.48 | Upgrade |
Loss (Gain) From Sale of Assets | -0.03 | -0.03 | -0.04 | 0.04 | - | - | Upgrade |
Asset Writedown & Restructuring Costs | 0.15 | 0.15 | 3.45 | - | 0.83 | - | Upgrade |
Loss (Gain) From Sale of Investments | - | - | - | - | 0.05 | 0.17 | Upgrade |
Stock-Based Compensation | 2.02 | 1.64 | 1.77 | 2.84 | 2.2 | 0.66 | Upgrade |
Provision & Write-off of Bad Debts | 0.01 | 0.01 | 0.09 | 0.13 | 1.72 | - | Upgrade |
Other Operating Activities | -1.07 | - | - | - | -0.43 | - | Upgrade |
Change in Accounts Receivable | -0.01 | -0.01 | -0.03 | 0.01 | 0.05 | -0.04 | Upgrade |
Change in Inventory | 0.17 | 0.18 | 1.01 | 0.9 | 1.93 | -1.23 | Upgrade |
Change in Accounts Payable | -0.14 | 0.11 | 0.24 | -0.45 | 0.5 | -0.29 | Upgrade |
Change in Other Net Operating Assets | -0.78 | -0.35 | 0.67 | 0.34 | 0.05 | -1.73 | Upgrade |
Operating Cash Flow | -5.54 | -4.8 | -5.2 | -7.05 | -7.46 | -10.8 | Upgrade |
Capital Expenditures | -0.08 | -0.11 | -0.14 | -0.31 | -0.24 | -1.47 | Upgrade |
Sale of Property, Plant & Equipment | 0.7 | 0.04 | 0.04 | 0.54 | 0.03 | - | Upgrade |
Sale (Purchase) of Intangibles | -0.64 | -0.37 | -0.38 | -0.31 | -0.54 | -0.12 | Upgrade |
Investment in Securities | -0.03 | - | 0.15 | -0.15 | - | 4.98 | Upgrade |
Investing Cash Flow | -0.04 | -0.44 | -0.32 | -0.24 | -0.74 | 3.39 | Upgrade |
Long-Term Debt Issued | - | - | - | - | - | 0.53 | Upgrade |
Total Debt Issued | - | - | - | - | - | 0.53 | Upgrade |
Long-Term Debt Repaid | - | -0 | -0 | -0 | -0 | - | Upgrade |
Total Debt Repaid | -0 | -0 | -0 | -0 | -0 | - | Upgrade |
Net Debt Issued (Repaid) | -0 | -0 | -0 | -0 | -0 | 0.53 | Upgrade |
Issuance of Common Stock | 5.11 | 4.45 | 3.53 | 0.1 | 4.14 | 14.16 | Upgrade |
Financing Cash Flow | 5.11 | 4.45 | 3.52 | 0.1 | 4.14 | 14.69 | Upgrade |
Foreign Exchange Rate Adjustments | 0.03 | -0.01 | -0.01 | -0.08 | -0.03 | 0.02 | Upgrade |
Net Cash Flow | -0.44 | -0.79 | -2 | -7.26 | -4.09 | 7.29 | Upgrade |
Free Cash Flow | -5.63 | -4.91 | -5.34 | -7.36 | -7.7 | -12.27 | Upgrade |
Free Cash Flow Margin | -508.68% | -386.07% | -396.80% | -807.57% | -1939.04% | -1366.37% | Upgrade |
Free Cash Flow Per Share | -0.07 | -0.06 | -0.09 | -0.14 | -0.15 | -0.29 | Upgrade |
Levered Free Cash Flow | -2.52 | -2.91 | -3.17 | -3.37 | -2.47 | -9.21 | Upgrade |
Unlevered Free Cash Flow | -2.52 | -2.91 | -3.17 | -3.37 | -2.47 | -9.21 | Upgrade |
Change in Working Capital | -0.76 | -0.07 | 1.89 | 0.79 | 2.54 | -3.29 | Upgrade |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.